<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Adenosine</title>
    <link rel="stylesheet" href="./meds.css" />
    <script src="./med.js"></script>
  </head>
  <body>
    <table class="margin-bottom margin-right">
      <thead>
        <th class="backBtn" colspan="7"><a href="./meds.html">Go Back</a></th>
      </thead>
      <thead>
        <th class="header">Adenosine</th>
        <th class="level red">
          <p>E</p>
          <p>M</p>
          <p>R</p>
        </th>
        <th class="level red">
          <p>E</p>
          <p>M</p>
          <p>T</p>
        </th>
        <th class="level red">
          <p>A</p>
          <p>E</p>
          <p>M</p>
          <p>T</p>
        </th>
        <th class="level green">
          <p>I</p>
          <p>N</p>
          <p>T</p>
        </th>
        <th class="level green">
          <p>P</p>
          <p>M</p>
        </th>
        <th class="level green">
          <p>A</p>
          <p>P</p>
          <p>M</p>
        </th>
      </thead>
    </table>
    <table class="content margin-bottom">
      <tr>
        <td>Generic Name:</td>
        <td>Adenosine (ah-den'oh-seen)</td>
      </tr>
      <tr>
        <td>Trade Name:</td>
        <td>Adenocard&reg</td>
      </tr>
      <tr>
        <td>Chemical Class:</td>
        <td>Endogenous nucleoside</td>
      </tr>
      <tr>
        <td>Therapuetic Class:</td>
        <td>Antiarrhythmic</td>
      </tr>
      <tr>
        <td>Actions:</td>
        <td>
          Adenosine is a naturally occurring substance that is present in all body cells. Adenosine decreases conduction
          of the electrical impulse through the AV node and interrupts AV reentry pathways in paroxysmal
          supraventricular tachycardia (PSVT). It can effectively terminate rapid supraventricular tachycardia such as
          PSVT. Because of its rapid onset and very short half-life, the administration of adenosine is sometimes
          referred to as chemical cardioversion. A single bolus of the drug was effective in converting PSVT to a normal
          sinus rhythm in a significant number (90%) of patients in initial drug studies.
        </td>
      </tr>
      <tr>
        <td>Pharmacokinetics:</td>
        <td>Cleared from plasma in less than 30 seconds; t<sub>1/2</sub> = 10 seconds</td>
      </tr>
      <tr>
        <td>Indications</td>
        <td>
          <ul>
            <li>Unstable narrow QRS tachycardia refractory to vagal manueuvers</li>
            <li>Stable, regular, monomorphic wide-complex tachycardia</li>
          </ul>
        </td>
      </tr>
      <tr>
        <td>Contraindications:</td>
        <td>
          <ul>
            <li>Second- or third-degree heart block</li>
            <li>Sick sinus syndrome</li>
            <li>Hypersensitivity to the drug</li>
            <li>Bradycardia</li>
            <li>Bronchoconstrictive lung disease (i.e. asthma)</li>
            <li>Irregular wide-complex tachycardias</li>
          </ul>
        </td>
      </tr>
      <tr>
        <td>Precautions:<br /><span class="highlight" onclick="pregnancyCat('C')">Pregnancy Cat. C</span></td>
        <td>
          Adenosine typically causes dysrhythmias at the time of cardioversion. These generally last a few seconds or
          less and may include PVCs, PACs, sinus bradycardia, sinus tachycardia, and various degress of AV block. In
          extreme cases, transient asystole may occur. If this occurs, appropriate therapy should be initiated.
        </td>
      </tr>
      <tr>
        <td>Side Effects:</td>
        <td>
          <ul>
            <li><b>CNS:</b> dizziness, headache</li>
            <li>
              <b>CV:</b> dysrhythmia outlined under precautions, chest pain, facial flushing, palpitations, diaphoresis
            </li>
            <li><b>GI:</b> nausea</li>
            <li><b>RESP:</b> chest pressure, dyspnea</li>
          </ul>
        </td>
      </tr>
      <tr>
        <td>Administration:</td>
        <td>
          <ul>
            <li><b>Adult:</b> Give 6 mg IV over 1 to 3 seconds, if not effective after 2 minutes, give 12 mg IV.</li>
            <li>
              <b>Pediatric:</b> Give 0.1 mg/kg IV over 1 to 3 seconds (maximum first doese 6 mg). If not effective after
              2 minutes, give 0.2 mg/kg IV (maximum second dose 12 mg)
            </li>
          </ul>
        </td>
      </tr>
      <tr>
        <td>Supply:</td>
        <td>Vials or prefilled syringes containing 6 mg in 2 mL</td>
      </tr>
      <tr>
        <td>Notes:</td>
        <td>
          <ul>
            <li>
              Give adenosine rapidly over 1 to 3 second, into the medication administration port closest to the patient,
              through a large (e.g., antecubital) vein followed by a 10 mL saline flush and elevation of the arm
            </li>
            <li>
              Higher doses than usual may be needed for patients receiving theophylline preparations or consuming large
              quantities of caffeine.
            </li>
            <li>
              Dipyridamole (Persantine) can potentiate the effects of adenosine. The dosage of adenosine may need to be
              reduce in patients receiving dipyridamole.
            </li>
            <li>
              Use of adenosine for irregular wide-complex tachycardias may cause degenerations of the rhythm to VF.
            </li>
          </ul>
        </td>
      </tr>
    </table>
  </body>
</html>
